Selected article for: "corona virus virus and respiratory syndrome"
Author: Mondal, Samhati; Quintili, Ashley L.; Karamchandani, Kunal; Bose, Somnath
Title: Thromboembolic disease in COVID-19 patients: A brief narrative review
  • Cord-id: cmrtg91a
  • Document date: 2020_9_14
    • ID: cmrtg91a
    Snippet: Corona virus 2 (SARS-CoV2/ Severe Acute Respiratory Syndrome Corona Virus 2) infection has emerged as a global health crisis. Incidence of thromboembolic disease is reported to be high in SARS-CoV2 disease and is seen in a multitude of organ systems ranging from cutaneous thrombosis to pulmonary embolism, stroke or coronary thrombosis sometimes with catastrophic outcomes. Evidence points towards a key role of thromboembolism, hypercoagulability and over production of proinflammatory cytokines mi
    Document: Corona virus 2 (SARS-CoV2/ Severe Acute Respiratory Syndrome Corona Virus 2) infection has emerged as a global health crisis. Incidence of thromboembolic disease is reported to be high in SARS-CoV2 disease and is seen in a multitude of organ systems ranging from cutaneous thrombosis to pulmonary embolism, stroke or coronary thrombosis sometimes with catastrophic outcomes. Evidence points towards a key role of thromboembolism, hypercoagulability and over production of proinflammatory cytokines mimicking a “cytokine storm” which leads to multiorgan failure. This brief narrative review highlights the pathophysiology and risk factors of thromboembolic disease and provides a framework for management of anticoagulation based on the current evidence.

    Search related documents:
    Co phrase search for related documents
    • active malignancy and long term follow: 1
    • active malignancy and lung limited: 1, 2
    • active surveillance and acute ards respiratory distress syndrome: 1, 2
    • active surveillance and acute phase: 1, 2
    • active surveillance and long term follow: 1
    • acute ards respiratory distress syndrome and admit patient: 1
    • acute ards respiratory distress syndrome and lmwh weight heparin: 1, 2, 3, 4, 5, 6, 7
    • acute ards respiratory distress syndrome and long term follow: 1, 2, 3, 4, 5
    • acute ards respiratory distress syndrome and low molecular lmwh weight heparin: 1, 2, 3, 4, 5, 6, 7
    • acute ards respiratory distress syndrome and lung autopsy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute ards respiratory distress syndrome and lung limited: 1, 2, 3, 4, 5, 6
    • acute ards respiratory distress syndrome and lung parenchyma: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • acute phase and lmwh weight heparin: 1, 2
    • acute phase and long term follow: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • acute phase and low molecular lmwh weight heparin: 1, 2
    • acute phase and lung autopsy: 1, 2, 3
    • acute phase and lung limited: 1, 2
    • acute phase and lung parenchyma: 1, 2, 3, 4
    • lmwh weight heparin and low molecular lmwh weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25